Technology
Health
Biotechnology
Eloxx Pharmaceuticals
$12.179876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.03 (-7.80%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ELOX and other stocks, options, ETFs, and crypto commission-free!
About
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Read More It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.
Employees
29
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
473.35M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
89.01K
High Today
$13.21
Low Today
$12.17
Open Price
$13.21
Volume
9.31K
52 Week High
$24.60
52 Week Low
$7.30
Collections
Technology
Health
Biotechnology
Medical
2018 IPO
US
North America
News
The Motley FoolMar 8
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q4 2018 Earnings Conference Call , 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, everyone, and welcome to Eloxx Pharmaceuticals Fourth Quarter and Full-Year 2018 Earnings Webcast and Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations Officer. Please begin. Barbara Ryan -- Investor Relations O...
Price Paid on Robinhood
15% Lower
Right Now
52 Week Low
$7.30
Average Price Paid
$14.27
52 Week High
$24.60
Earnings
-$0.48
-$0.43
-$0.37
-$0.32
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
-$0.40 per share